UK markets close in 6 hours 23 minutes

Novozymes A/S (NVZMY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
58.85-0.50 (-0.84%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.32B
Enterprise value 28.28B
Trailing P/E 37.22
Forward P/E 26.04
PEG ratio (5-yr expected) 1.14
Price/sales (ttm)6.29
Price/book (mrq)13.45
Enterprise value/revenue 1.58
Enterprise value/EBITDA 5.17

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 315.30%
S&P500 52-week change 329.57%
52-week high 361.86
52-week low 338.75
50-day moving average 355.51
200-day moving average 349.48

Share statistics

Avg vol (3-month) 319.33k
Avg vol (10-day) 310.23k
Shares outstanding 5464.36M
Implied shares outstanding 6468.75M
Float 8352.8M
% held by insiders 10.00%
% held by institutions 10.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.19
Forward annual dividend yield 42.02%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.56
Payout ratio 493.21%
Dividend date 301 Nov 2023
Ex-dividend date 420 Oct 2023
Last split factor 25:1
Last split date 309 Dec 2011

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 16.90%
Operating margin (ttm)23.20%

Management effectiveness

Return on assets (ttm)9.90%
Return on equity (ttm)21.27%

Income statement

Revenue (ttm)17.9B
Revenue per share (ttm)64.61
Quarterly revenue growth (yoy)1.60%
Gross profit (ttm)N/A
EBITDA 5.63B
Net income avi to common (ttm)3.02B
Diluted EPS (ttm)1.58
Quarterly earnings growth (yoy)-21.00%

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)2.4
Total debt (mrq)7.78B
Total debt/equity (mrq)54.22%
Current ratio (mrq)1.30
Book value per share (mrq)50.40

Cash flow statement

Operating cash flow (ttm)4.15B
Levered free cash flow (ttm)2.14B